Sio Gene Therapies Inc. Stock Split Ratio
Sio Gene Therapies Inc. reported Stock Split Ratio of 12.50% for the 11-month period ending 2020-03-31, per its 10-K filed 2021-06-09.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2021-06-09
- 2020-03-31: Stockholders' Equity Note, Stock Split, Conversion Ratio 11 month 12.50%.
- 2019-05-08: Stockholders' Equity Note, Stock Split, Conversion Ratio 12.50%.
- 2015-03-18: Stockholders' Equity Note, Stock Split, Conversion Ratio 10000000.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 11 month |
|---|---|---|
| 2020-03-31 | 12.50% 10-K · filed 2021-06-09 | |
| 2019-05-08 | 12.50% 10-K · filed 2021-06-09 | |
| 2015-03-18 | 10000000.00% 10-K · filed 2018-06-11 |